Gregory P Forlenza
Overview
Explore the profile of Gregory P Forlenza including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
124
Citations
2585
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leung H, Gong C, Geiser L, Fivekiller E, Bui N, Vu T, et al.
Sci Rep
. 2025 Mar;
15(1):8877.
PMID: 40087308
Diabetes affects millions in the US, causing elevated blood glucose levels that could lead to complications like kidney failure and heart disease. Recent development of continuous glucose monitors has enabled...
2.
Sobczak M, Pyle L, Sawyer A, Forlenza G, Alonso G
Diabetes Technol Ther
. 2025 Feb;
PMID: 39937145
Hemoglobin A1c (A1c) is the standard for glycemic control in type 1 diabetes. With recent increase in continuous glucose monitoring (CGM), other metrics (time in range 70-180 mg/dL [TIR]) are...
3.
Kartik R, Akturk H, Stewart M, Forlenza G
Diabetes Technol Ther
. 2024 Dec;
PMID: 39714954
No abstract available.
4.
Moser O, Zaharieva D, Adolfsson P, Battelino T, Bracken R, Buckingham B, et al.
Horm Res Paediatr
. 2024 Dec;
:1-28.
PMID: 39657609
Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved...
5.
Moser O, Zaharieva D, Adolfsson P, Battelino T, Bracken R, Buckingham B, et al.
Diabetologia
. 2024 Dec;
68(2):255-280.
PMID: 39653802
Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved...
6.
Brown S, Laffel L, Akturk H, Forlenza G, Shah V, Wadwa R, et al.
Diabetes Technol Ther
. 2024 Nov;
PMID: 39601043
We evaluated a modified version of Control-IQ technology with a lower treatment range and a modified meal bolus module in adults, adolescents, children, and preschoolers with type 1 diabetes in...
7.
MacLeish S, Hood K, Polonsky W, Wood J, Bode B, Forlenza G, et al.
Diabetes Obes Metab
. 2024 Sep;
26(12):5569-5579.
PMID: 39300963
Aim: Automated insulin delivery (AID) systems have demonstrated improved glycaemic outcomes in people with type 1 diabetes (T1D), yet limited data exist on these systems in very young children and...
8.
Ekhlaspour L, Buckingham B, Bauza C, Clements M, Forlenza G, Neyman A, et al.
J Clin Transl Endocrinol
. 2024 Jun;
36:100352.
PMID: 38860154
Objectives: To report the safety and side effects associated with taking verapamil for beta-cell preservation in children with newly-diagnosed T1D. Research Design And Methods: Eighty-eight participants aged 8.5 to 17.9 ...
9.
Xu T, Jost E, Messer L, Cook P, Forlenza G, Sankaranarayanan S, et al.
Proc SIGCHI Conf Hum Factor Comput Syst
. 2024 Jun;
2024.
PMID: 38846748
Learning personalized self-management routines is pivotal for people with type 1 diabetes (T1D), particularly early in diagnosis. Context-aware technologies, such as hybrid closed-loop (HCL) insulin pumps, are important tools for...
10.
Cobry E, Vigers T, Berget C, Messer L, Wadwa R, Pyle L, et al.
Diabetes Spectr
. 2024 May;
37(2):118-123.
PMID: 38756430
Background: Meeting glycemic recommendations is challenging for youth with type 1 diabetes. Diabetes technology, including continuous glucose monitoring (CGM) and hybrid closed-loop (HCL) automated insulin delivery systems, significantly increase achievement...